CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Extrawell Pharmaceutical Holdings Ltd. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Extrawell Pharmaceutical Holdings Ltd.
Suites 2206-08, 22nd Floor, Devon House,
Taikoo Place, 979 King's Road,Quarry Bay
Phone: +852 28561918p:+852 28561918 Hong Kong Ticker: 858858

Business Summary
Extrawell Pharmaceutical Holdings Limited is a Hong Kong-based investment holding company principally engaged in the trading of pharmaceutical products. The Company mainly operates through three segments. The Manufacturing segment is engaged in the development, manufacture and sales of pharmaceutical products. Its manufactured products include Transfer Factor Oral Solution, Wisk and ZhouBang, among others. The Trading segment is engaged in the marketing and distribution of imported pharmaceutical products. Its imported products include GM 1, Millibar and Skin Cap. The Gene Development segment is engaged in the commercial exploitation and development of genome-related technologies.
(Source: ARS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
YesYes-------

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/20193/31/2019Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board, Chief Executive Officer YiXie 51 12/5/2013 1/1/2001
General Manager of Changchun Extrawell Pharmaceutical Co., Ltd. and Director - Operations of Jilin Lian BangChan 59
Financial Controller, Executive Director, Joint Company Secretary Kwok WahLiu 52 1/8/2014 11/3/2008
9 additional Officers and Directors records available in full report.

Business Names
Business Name
858
Extrawell Pharmaceutical Holdings Ltd.
Jilin Extrawell Changbaishan Pharmaceutical Co., Ltd.

General Information
Number of Employees: 171 (As of 3/31/2019)
Outstanding Shares: 2,390,000,000 (As of 3/31/2019)
Shareholders: 1,955
Stock Exchange: HKG
Fax Number: +852 28563139


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, December 05, 2019